Does FOSTAMATINIB Cause Product prescribing issue? 206 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Product prescribing issue have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 3.2% of all adverse event reports for FOSTAMATINIB.
206
Reports of Product prescribing issue with FOSTAMATINIB
3.2%
of all FOSTAMATINIB reports
11
Deaths
45
Hospitalizations
How Dangerous Is Product prescribing issue From FOSTAMATINIB?
Of the 206 reports, 11 (5.3%) resulted in death, 45 (21.8%) required hospitalization.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 206 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which FOSTAMATINIB Alternatives Have Lower Product prescribing issue Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM